|
1
|
Priyanka A, Akshatha K, Deekshit VK,
Prarthana J and Akhila DS: Klebsiella pneumoniae infections
and antimicrobial drug resistance. Model organisms for microbial
pathogenesis, biofilm formation and antimicrobial drug discovery.
Springer. (Singapore). 195–225. 2020. View Article : Google Scholar
|
|
2
|
Giacobbe DR, Di Pilato V, Karaiskos I,
Giani T, Marchese A, Rossolini GM and Bassetti M: Treatment and
diagnosis of severe KPC-producing Klebsiella pneumoniae
infections: A perspective on what has changed over last decades.
Ann Med. 55:101–113. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang S, Zhang X, Wu Q, Zheng X, Dong G,
Fang R, Zhang Y, Cao J and Zhou T: Clinical, microbiological, and
molecular epidemiological characteristics of Klebsiella
pneumoniae-induced pyogenic liver abscess in southeastern
China. Antimicrob Resist Infect Control. 8:1662019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Al Ismail D, Campos-Madueno EI, Donà V and
Endimiani A: Hypervirulent Klebsiella pneumoniae (hvKp):
Overview, epidemiology, and laboratory detection. Pathog Immun.
10:80–119. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marr CM and Russo TA: Hypervirulent
Klebsiella pneumoniae: A new public health threat. Expert
Rev Anti Infect Ther. 17:71–73. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Choby JE, Howard-Anderson J and Weiss DS:
Hypervirulent Klebsiella pneumoniae-clinical and molecular
perspectives. J Intern Med. 287:283–300. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sohrabi M, Alizade Naini M, Rasekhi A,
Oloomi M, Moradhaseli F, Ayoub A, Bazargani A, Hashemizadeh Z,
Shahcheraghi F and Badmasti F: Emergence of K1 ST23 and K2 ST65
hypervirulent Klebsiella pneumoniae as true pathogens with
specific virulence genes in cryptogenic pyogenic liver abscesses
Shiraz Iran. Front Cell Infect Microbiol. 12:9642902022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Berman JJ: Changing how we think about
infectious diseases. Taxonomic guide to infectious diseases.
(second edition). Elsevier; pp. 321–365. 2019, View Article : Google Scholar
|
|
9
|
Liao CH, Huang YT, Chang CY, Hsu HS and
Hsueh PR: Capsular serotypes and multilocus sequence types of
bacteremic Klebsiella pneumoniae isolates associated with
different types of infections. Eur J Clin Microbiol Infect Dis.
33:365–369. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mendes G, Santos ML, Ramalho JF, Duarte A
and Caneiras C: Virulence factors in carbapenem-resistant
hypervirulent Klebsiella pneumoniae. Front Microbiol.
14:13250772023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thirugnanasambantham MK, Thuthikkadu
Indhuprakash S and Thirumalai D: Phenotypic and genotypic
characteristics of hypervirulent Klebsiella pneumoniae
(hvKp): A narrative review. Curr Microbiol. 82:3412025. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ding L, Shen S, Chen J, Tian Z, Shi Q, Han
R, Guo Y and Hu F: Klebsiella pneumoniae carbapenemase
variants: The new threat to global public health. Clin Microbiol
Rev. 36:e00008232023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Khan AU, Maryam L and Zarrilli R:
Structure, genetics and worldwide spread of New Delhi
metallo-β-lactamase (NDM): A threat to public health. BMC
Microbiol. 17:1012017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shah AA, Alwashmi AS, Abalkhail A and
Alkahtani AM: Emerging challenges in Klebsiella pneumoniae:
Antimicrobial resistance and novel approach. Microb. Pathog.
202:1073992025.PubMed/NCBI
|
|
15
|
Hetta HF, Alanazi FE, Ali MAS, Alatawi AD,
Aljohani HM, Ahmed R, Alansari NA, Alkhathami FM, Albogmi A,
Alharbi BM, et al: Hypervirulent Klebsiella pneumoniae:
Insights into virulence, antibiotic resistance, and fight
strategies against a superbug. Pharmaceuticals (Basel). 18:7242025.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pan Y, Chen H, Ma R, Wu Y, Lun H, Wang A,
He K, Yu J and He P: A novel depolymerase specifically degrades the
K62-type capsular polysaccharide of Klebsiella pneumoniae.
One Health Adv. 2:52024. View Article : Google Scholar
|
|
17
|
Xu Q, Liu C, Wu Z, Zhang S, Chen Z, Shi Y
and Gu S: Demographics and prognosis of patients with pyogenic
liver abscess due to Klebsiella pneumonia or other species.
Heliyon. 10:e294632024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pandita A, Javaid W and Fazili T: Liver
Abscess. In: Introduction to Clinical Infectious Diseases.
Domachowske J: Springer; Cham: pp. 147–155. 2019
|
|
19
|
Lam JC and Stokes W: Management of
pyogenic liver abscesses: Contemporary strategies and challenges. J
Clin Gastroenterol. 57:774–781. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Clegg S and Murphy CN: Epidemiology and
virulence of Klebsiella pneumoniae. Urinary tract
infections: Molecular pathogenesis and clinical management.
435–457. 2017.
|
|
21
|
Abbas R, Chakkour M, Zein El Dine H,
Obaseki EF, Obeid ST, Jezzini A, Ghssein G and Ezzeddine Z: General
overview of Klebsiella pneumonia: Epidemiology and the role
of siderophores in its pathogenicity. Biology (Basel).
13:782024.PubMed/NCBI
|
|
22
|
Chen Q, Wang M, Han M, Xu L and Zhang H:
Molecular basis of Klebsiella pneumoniae colonization in
host. Microb Pathog. 177:1060262023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wantuch PL and Rosen DA: Klebsiella
pneumoniae: Adaptive immune landscapes and vaccine horizons.
Trends Immunol. 44:826–844. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ke Y, Zeng Z, Liu J and Ye C: Capsular
polysaccharide as a potential target in hypervirulent and
drug-resistant Klebsiella pneumoniae treatment. Infect Drug
Resist. 18:1253–1262. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Igweonu CF: Molecular characterization of
antibiotic resistance genes in multidrug-resistant Klebsiella
pneumoniae clinical isolates. Int J Eng Technol Res Manag.
8:2412024.
|
|
26
|
Haque M, Sartelli M, McKimm J and Bakar
MA: Health care-associated infections-an overview. Infect Drug
Resist. 11:2321–2333. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ye M, Tu J, Jiang J, Bi Y, You W, Zhang Y,
Ren J, Zhu T, Cao Z, Yu Z, et al: Clinical and genomic analysis of
liver abscess-causing Klebsiella pneumoniae identifies new
liver abscess-associated virulence genes. Front Cell Infect
Microbiol. 6:1652016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wichmann D, Königsrainer A, Schweizer U,
Archid R, Nadalin S and Manncke S: Pyogenic liver abscesses caused
by acute appendicitis: Frequency and diagnostic and therapeutic
recommendations. Surg Infect (Larchmt). 22:253–257. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Serban D, Popa Cherecheanu A, Dascalu AM,
Socea B, Vancea G, Stana D, Smarandache GC, Sabau AD and Costea DO:
Hypervirulent Klebsiella pneumoniae endogenous
endophthalmitis-a global emerging disease. Life (Basel).
11:6762021.PubMed/NCBI
|
|
30
|
Neill L, Edwards F, Collin SM, Harrington
D, Wakerley D, Rao GG and McGregor AC: Clinical characteristics and
treatment outcomes in a cohort of patients with pyogenic and
amoebic liver abscess. BMC Infect Dis. 19:4902019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thimmappa PY, Vasishta S, Ganesh K, Nair
AS and Joshi MB: Neutrophil (dys)function due to altered
immuno-metabolic axis in type 2 diabetes: Implications in combating
infections. Hum Cell. 36:1265–1282. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gan C, Yuan Y, Shen H, Gao J, Kong X, Che
Z, Guo Y, Wang H, Dong E and Xiao J: Liver diseases: Epidemiology,
causes, trends and predictions. Signal Transduct Target Ther.
10:332025. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Angeles-Solano M, Tabashsum Z, Chen L and
Rowe SE: Klebsiella pneumoniae liver abscesses:
Pathogenesis, treatment, and ongoing challenges. Infect Immun.
93:e00508242025. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nakamura K, Nomoto H, Harada S, Suzuki M,
Yomono K, Yokochi R, Hagino N, Nakamoto T, Moriyama Y, Yamamoto K,
et al: Infection with capsular genotype K1-ST23 hypervirulent
Klebsiella pneumoniae isolates in Japan after a stay in East
Asia: Two cases and a literature review. J Infect Chemother.
27:1508–1512. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
García-Cobos S, Oteo-Iglesias J and
Pérez-Vázquez M: Hypervirulent Klebsiella pneumoniae:
Epidemiology outside Asian countries, antibiotic resistance
association, methods of detection and clinical management. Enferm
Infecc Microbiol Clin (Engl Ed). 43:102–109. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kain MJ, Reece NL, Parry CM, Rajahram GS,
Paterson DL and Woolley SD: The rapid emergence of hypervirulent
klebsiella species and burkholderia pseudomallei as major health
threats in southeast Asia: The urgent need for recognition as
neglected tropical diseases. Trop Med Infect Dis. 9:802024.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li X, Chen S, Lu Y, Shen W, Wang W, Gao J,
Gao J, Shao P and Zhou Z: Molecular epidemiology and genetic
dynamics of carbapenem-resistant hypervirulent Klebsiella
pneumoniae in China. Front Cell Infect Microbiol.
15:15299292025. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Isler B, Aslan AT, Akova M, Harris P and
Paterson DL: Treatment strategies for OXA-48-like and NDM producing
Klebsiella pneumoniae infections. Expert Rev Anti Infect
Ther. 20:1389–1400. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang Y, McNally A and Zong Z: Call for
prudent use of the term hypervirulence in carbapenem-resistant
Klebsiella pneumoniae. Lancet Microbe. 6:1010902025.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Russo TA, Alvarado CL, Davies CJ, Drayer
ZJ, Carlino-MacDonald U, Hutson A, Luo TL, Martin MJ, Corey BW,
Moser KA, et al: Differentiation of hypervirulent and classical
Klebsiella pneumoniae with acquired drug resistance. mBio.
15:e02867232024. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Han B, Feng C, Jiang Y, Ye C, Wei Y, Liu J
and Zeng Z: Mobile genetic elements encoding antibiotic resistance
genes and virulence genes in Klebsiella pneumoniae:
Important pathways for the acquisition of virulence and resistance.
Front Microbiol. 16:15291572025. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu C, Huang Y, Zhou P, Gao H, Wang B, Zhao
H, Zhang J, Wang L, Zhou Y and Yu F: Emergence of hypervirulent and
carbapenem-resistant Klebsiella pneumoniae from 2014–2021 in
Central and Eastern China: A molecular, biological, and
epidemiological study. BMC Microbiol. 24:4652024. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu S, Huang Z, Kong J, Zhao Y, Xu M, Zhou
B, Zheng X, Ye D, Zhou T, Cao J and Zhou C: Effects of
aerobactin-encoding gene iucB and regulator of mucoid phenotype
rmpA on the virulence of Klebsiella pneumoniae causing liver
abscess. Front Cell Infect Microbiol. 12:9689552022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chan KS, Chia CTW and Shelat VG:
Demographics, radiological findings, and clinical outcomes of
Klebsiella pneumonia vs non-Klebsiella pneumoniae pyogenic
liver abscess: A systematic review and meta-analysis with trial
sequential analysis. Pathogens. 11:9762022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shein AMS: Mechanisms of colistin
resistance and the antimicrobial effects of antibiotic and adjuvant
combination on colistin-resistant Klebsiella pneumoniae.
Chulalongkorn University Theses and Dissertations (Chula ETD); pp.
47862021
|
|
46
|
Xu L, Li J, Wu W, Wu X and Ren J:
Klebsiella pneumoniae capsular polysaccharide: Mechanism in
regulation of synthesis, virulence, and pathogenicity. Virulence.
15:24395092024. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Walker KA and Miller VL: The intersection
of capsule gene expression, hypermucoviscosity and hypervirulence
in Klebsiella pneumoniae. Curr Opin Microbiol. 54:95–102.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Walker KA, Miner TA, Palacios M, Trzilova
D, Frederick DR, Broberg CA, Sepúlveda VE, Quinn JD and Miller VL:
A Klebsiella pneumoniae regulatory mutant has reduced
capsule expression but retains hypermucoviscosity. mBio.
10:e00089–19. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yu WL, Lee MF, Chang MC and Chuang YC:
Intrapersonal mutation of rmpA and rmpA2: A reason for negative
hypermucoviscosity phenotype and low virulence of rmpA-positive
Klebsiella pneumoniae isolates. J Glob Antimicrob Resist.
3:137–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Opoku-Temeng C, Kobayashi SD and DeLeo FR:
Klebsiella pneumoniae capsule polysaccharide as a target for
therapeutics and vaccines. Comput Struct Biotechnol J.
17:1360–1366. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kumar A, Chakravorty S, Yang T, Russo TA,
Newton SM and Klebba PE: Siderophore-mediated iron acquisition by
Klebsiella pneumoniae. J Bacteriol. 206:e00024242024.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Russo TA, Olson R, MacDonald U, Beanan J
and Davidson BA: Aerobactin, but not yersiniabactin, salmochelin,
or enterobactin, enables the growth/survival of hypervirulent
(hypermucoviscous) Klebsiella pneumoniae ex vivo and in
vivo. Infect Immun. 83:3325–3333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Holden VI, Breen P, Houle S, Dozois CM and
Bachman MA: Klebsiella pneumoniae siderophores induce
inflammation, bacterial dissemination, and HIF-1α stabilization
during pneumonia. mBio. 7:e01397–16. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wu J, Chen J, Wang Y, Meng Q and Zhao J:
Siderophore iucA of hypermucoviscous Klebsiella pneumoniae
promotes liver damage in mice by inducing oxidative stress. Biochem
Biophys Rep. 32:1013762022.PubMed/NCBI
|
|
55
|
Lim C, Zhang CY, Cheam G, Chu WHW, Chen Y,
Yong M, Lim KYE, Lam MMC, Teo TH and Gan YH: Essentiality of the
virulence plasmid-encoded factors in disease pathogenesis of the
major lineage of hypervirulent Klebsiella pneumoniae varies
in different infection niches. EBioMedicine. 115:1056832025.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Doorduijn DJ, Rooijakkers SH, van Schaik W
and Bardoel BW: Complement resistance mechanisms of Klebsiella
pneumoniae. Immunobiology. 221:1102–1109. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Singh S, Wilksch JJ, Dunstan RA, Mularski
A, Wang N, Hocking D, Jebeli L, Cao H, Clements A, Jenney AWJ, et
al: LPS O antigen plays a key role in Klebsiella pneumoniae
capsule retention. Microbiol Spectr. 10:e01517212022. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yang FL, Yang YL, Liao PC, Chou JC, Tsai
KC, Yang AS, Sheu F, Lin TL, Hsieh PF, Wang JT, et al: Structure
and immunological characterization of the capsular polysaccharide
of a pyrogenic liver abscess caused by Klebsiella
pneumoniae: Activation of macrophages through Toll-like
receptor 4. J Biol Chem. 286:21041–21051. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhu J, Wang T, Chen L and Du H: Virulence
factors in hypervirulent Klebsiella pneumoniae. Front
Microbiol. 12:6424842021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Lam MMC, Wyres KL, Judd LM, Wick RR,
Jenney A, Brisse S and Holt KE: Tracking key virulence loci
encoding aerobactin and salmochelin siderophore synthesis in
Klebsiella pneumoniae. Genome Med. 10:772018. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Shimpoh T, Hirata Y, Ihara S, Suzuki N,
Kinoshita H, Hayakawa Y, Ota Y, Narita A, Yoshida S, Yamada A and
Koike K: Prevalence of pks-positive Escherichia coli in Japanese
patients with or without colorectal cancer. Gut Pathog. 12:352017.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Kaur CP, Vadivelu J and Chandramathi S:
Impact of Klebsiella pneumoniae in lower gastrointestinal
tract diseases. J Dig Dis. 19:262–271. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Paczosa MK and Mecsas J: Klebsiella
pneumoniae: going on the offense with a strong defense.
Microbiol Mol Biol Rev. 80:629–661. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Chen T, Dong G, Zhang S, Zhang X, Zhao Y,
Cao J, Zhou T and Wu Q: Effects of iron on the growth, biofilm
formation and virulence of Klebsiella pneumoniae causing
liver abscess. BMC Microbiol. 20:362020. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Opoku-Temeng C, Malachowa N, Kobayashi SD
and DeLeo FR: Innate host defense against Klebsiella
pneumoniae and the outlook for development of immunotherapies.
J Innate Immun. 14:167–181. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Bai R and Guo J: Interactions and
implications of Klebsiella pneumoniae with human immune
responses and metabolic pathways: A comprehensive review. Infect
Drug Resist. 17:449–462. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Han HC: Role of macrophages and
neutrophils in Klebsiella pneumoniae induced liver abscess
(KLA). National University of Singapore (Singapore); 2019
|
|
68
|
Lin SH, Chung PH, Wu YY, Fung CP, Hsu CM
and Chen LW: Inhibition of nitric oxide production reverses
diabetes-induced Kupffer cell activation and Klebsiella
pneumonia liver translocation. PLoS One. 12:e01772692017.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Chen HQ, Mo ZH and Wei WX: Case report:
Trauma-induced Klebsiella pneumoniae invasive syndrome
presenting with liver abscess, lung abscess, endophthalmitis, and
purulent meningitis. Front Med (Lausanne). 11:15138312025.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Li S, Yu S, Peng M, Qin J, Xu C, Qian J,
He M and Zhou P: Clinical features and development of sepsis in
Klebsiella pneumoniae infected liver abscess patients: A
retrospective analysis of 135 cases. BMC Infect Dis. 21:5972021.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Hu Y, Anes J, Devineau S and Fanning S:
Klebsiella pneumoniae: Prevalence, reservoirs, antimicrobial
resistance, pathogenicity, and infection: A hitherto unrecognized
zoonotic bacterium. Foodborne Pathog Dis. 18:63–84. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Silvester R, Madhavan A, Kokkat A, Parolla
A, B M A, M H and Abdulla MH: Global surveillance of antimicrobial
resistance and hypervirulence in Klebsiella pneumoniae from
LMICs: An in-silico approach. Sci Total Environ. 802:1498592022.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Koli SV, Mali SV and Geevarghese J:
‘Global divide in carbapenem resistance and hypervirulence of
Klebsiella pneumonia: Comparing trends in India and
developed nations’-a comprehensive review. J Antibiot (Tokyo).
78:457–471. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Hu Y, Yang Y, Feng Y, Fang Q, Wang C, Zhao
F, McNally A and Zong Z: Prevalence and clonal diversity of
carbapenem-resistant Klebsiella pneumoniae causing neonatal
infections: A systematic review of 128 articles across 30
countries. PLoS Med. 20:e10042332023. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Hu YL, Bi SL, Zhang ZY and Kong NQ:
Correlation between antibiotics-resistance, virulence genes and
genotypes among Klebsiella pneumoniae clinical strains
isolated in Guangzhou, China. Curr Microbiol. 81:2892024.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Hsu JY, Chuang YC, Wang JT, Chen YC and
Hsieh SM: Healthcare-associated carbapenem-resistant Klebsiella
pneumoniae bloodstream infections: Risk factors, mortality, and
antimicrobial susceptibility, 2017–2019. J Formos Med Assoc.
120:1994–2002. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Elias R, Duarte A and Perdigão J: A
molecular perspective on colistin and Klebsiella pneumoniae:
Mode of action, resistance genetics, and phenotypic susceptibility.
Diagnostics (Basel). 11:11652021. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Padmini N, Ajilda AAK, Sivakumar N and
Selvakumar G: Extended spectrum β-lactamase producing Escherichia
coli and Klebsiella pneumoniae: critical tools for
antibiotic resistance pattern. J Basic Microbiol. 57:460–470. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
da Silva Y, Ferrari R, Marin VA and Junior
CAC: A global overview of β-lactam resistance genes in
Klebsiella pneumoniae. Open Infect Dis J. 11:22–34. 2019.
View Article : Google Scholar
|
|
80
|
Li Y, Kumar S, Zhang L and Wu H and Wu H:
Characteristics of antibiotic resistance mechanisms and genes of
Klebsiella pneumoniae. Open Med (Wars). 18:202307072023.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Gogry FA, Siddiqui MT, Sultan I and Haq
QMR: Current update on intrinsic and acquired colistin resistance
mechanisms in bacteria. Front Med (Lausanne). 8:6777202021.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Sugawara E, Kojima S and Nikaido H:
Klebsiella pneumoniae major porins OmpK35 and OmpK36 allow
more efficient diffusion of β-lactams than their Escherichia coli
homologs OmpF and OmpC. J Bacteriol. 198:3200–3208. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Albarri O, AlMatar M, Var I and Köksal F:
Antimicrobial resistance of clinical Klebsiella pneumoniae
isolates: Involvement of AcrAB and OqxAB efflux pumps. Curr Mol
Pharmacol. 17:e3103232152662024.PubMed/NCBI
|
|
84
|
Liu Y, Lin Y, Wang Z, Hu N, Liu Q, Zhou W,
Li X, Hu L, Guo J, Huang X and Zeng L: Molecular mechanisms of
colistin resistance in Klebsiella pneumoniae in a tertiary
care teaching hospital. Front Cell Infect Microbiol. 11:6735032021.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Di Pilato V, Pollini S, Miriagou V,
Rossolini GM and D'Andrea MM: Carbapenem-resistant Klebsiella
pneumoniae: The role of plasmids in emergence, dissemination,
and evolution of a major clinical challenge. Expert Rev Anti Infect
Ther. 22:25–43. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Arcari G and Carattoli A: Global spread
and evolutionary convergence of multidrug-resistant and
hypervirulent Klebsiella pneumoniae high-risk clones. Pathog
Glob Health. 117:328–341. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Merla C, Kuka A, Mileto I, Petazzoni G,
Gaiarsa S, De Vitis D, Ardizzone M, Corbella M, Baldanti F and
Cambieri P: One-year surveillance for hypervirulent Klebsiella
pneumoniae detected carbapenem-resistant superbugs. Microbiol
Spectr. 12:e03292232024.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Han YL, Wen XH, Zhao W, Cao XS, Wen JX,
Wang JR, Hu ZD and Zheng WQ: Epidemiological characteristics and
molecular evolution mechanisms of carbapenem-resistant
hypervirulent Klebsiella pneumoniae. Front Microbiol.
13:10037832022. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Rahmat Ullah S, Jamal M, Rahman A and
Andleeb S: Comprehensive insights into Klebsiella
pneumoniae: Unravelling clinical impact, epidemiological trends
and antibiotic-resistance challenges. J Antimicrob Chemother.
79:1484–1492. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Grégoire N, Aranzana-Climent V, Magréault
S, Marchand S and Couet W: Clinical pharmacokinetics and
pharmacodynamics of colistin. Clin Pharmacokinet. 56:1441–1460.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Zha L, Pan L, Guo J, French N, Villanueva
EV and Tefsen B: Effectiveness and safety of high dose tigecycline
for the treatment of severe infections: A systematic review and
meta-analysis. Adv Ther. 37:1049–1064. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Zhao T, Chen N, Zhang M, Lin L, Lin B,
Fang Y, Hua Z and Liang C: Bibliometric analysis of global research
on the clinical applications of aminoglycoside antibiotics:
Improving efficacy and decreasing risk. Front Microbiol.
16:15322312025. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Edwards F, MacGowan A and Macnaughton E:
Antimicrobial therapy: Principles of use. Medicine. 49:624–631.
2021. View Article : Google Scholar
|
|
94
|
Riccobono E, Bussini L, Giannella M, Viale
P and Rossolini GM: Rapid diagnostic tests in the management of
pneumonia. Expert Rev Mol Diagn. 22:49–60. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Nayeem A, Suresh AS, Vellapandian C, Singh
S, Elossaily GM and Prajapati BG: Comprehensive insights into
cephalosporins: Spectrum, generations, and clinical applications.
Curr Drug Ther. 2024. View Article : Google Scholar
|
|
96
|
Kaiser P, Wächter J and Windbergs M:
Therapy of infected wounds: Overcoming clinical challenges by
advanced drug delivery systems. Drug Deliv Transl Res.
11:1545–1567. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Trillos-Almanza MC and Gutierrez JCR: How
to manage: Liver abscess. Frontline Gastroenterol. 12:225–231.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Chang D, Sharma L, Dela Cruz CS and Zhang
D: Clinical epidemiology, risk factors, and control strategies of
Klebsiella pneumoniae infection. Front Microbiol.
12:7506622021. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Li F, Zhang H, Xu Y, Eresen A, Zhang Z and
Liu J: Clinical and CT comparative study of invasive and
non-invasive Klebsiella pneumoniae liver abscesses. Clin.
Radiol. 78:40–46. 2023.
|
|
100
|
Nojima H, Shimizu H, Murakami T, Yamazaki
M, Yamazaki K, Suzuki S, Shuto K, Kosugi C, Usui A and Koda K:
Successful hepatic resection for invasive Klebsiella
pneumoniae large multiloculated liver abscesses with
percutaneous drainage failure: A case report. Front Med (Lausanne).
9:10928792023. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Russo A, Fusco P, Morrone HL, Trecarichi
EM and Torti C: New advances in management and treatment of
multidrug-resistant Klebsiella pneumoniae. Expert Rev Anti
Infect Ther. 21:41–55. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Wang Q, Yan T, Ma C, Teng X, Shen C, Wang
N, Yu K, Chu W, Zhou Q and Liu Z: Poor glycemic control in
carbapenem-resistant Klebsiella pneumoniae infections:
Impact on epidemiological features, mortality risks, and polymyxin
resistance. Infect Drug Resist. 18:647–660. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Li Y, Kumar S and Zhang L: Mechanisms of
antibiotic resistance and developments in therapeutic strategies to
combat Klebsiella pneumoniae infection. Infect Drug Resist.
17:1107–1119. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Karaiskos I, Galani I, Papoutsaki V,
Galani L and Giamarellou H: Carbapenemase producing Klebsiella
pneumoniae: Implication on future therapeutic strategies.
Expert Rev Anti Infect Ther. 20:53–69. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Miller JC, Cross AS, Tennant SM and
Baliban SM: Klebsiella pneumoniae lipopolysaccharide as a
vaccine target and the role of antibodies in protection from
disease. Vaccines (Basel). 12:11772024. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Tiria FR and Musila L: A review of the
innate immune evasion mechanisms and status of vaccine development
of Klebsiella pneumonia. Microbiol Res J Int. 31:33–47.
2021. View Article : Google Scholar
|
|
107
|
Wantuch PL, Knoot CJ, Marino EC, Harding
CM and Rosen DA: Klebsiella pneumoniae bioconjugate vaccine
functional durability in mice. Vaccine. 43:1265362025. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Jiao X, Wang M, Liu Y, Yang S, Yu Q and
Qiao J: Bacteriophage-derived depolymerase: A review on prospective
antibacterial agents to combat Klebsiella pneumoniae. Arch
Virol. 170:702025. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Gholizadeh O, Ghaleh HEG, Tat M, Ranjbar R
and Dorostkar R: The potential use of bacteriophages as
antibacterial agents against Klebsiella pneumoniae. Virol J.
21:1912024. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Yoo S, Lee KM, Kim N, Vu TN, Abadie R and
Yong D: Designing phage cocktails to combat the emergence of
bacteriophage-resistant mutants in multidrug-resistant
Klebsiella pneumoniae. Microbiol Spectr. 12:e01258232024.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Noor K and Shehzad MI: Gene-targeted
antimicrobial strategies using CRISPR-cas systems against
multidrug-resistant bacterial pathogens. Int J Appl Clin Res.
3:1–7. 2025.
|
|
112
|
Tang M, Kong X, Hao J and Liu J:
Epidemiological characteristics and formation mechanisms of
multidrug-resistant hypervirulent Klebsiella pneumoniae.
Front Microbiol. 11:5815432020. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Lindstedt K: Human gut colonisation by the
Klebsiella pneumoniae species complex: Detection, duration,
dynamics, and microbiota associations. 2024.
|
|
114
|
Elbehiry A and Abalkhail A: Spectral
precision: Recent advances in matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry for pathogen
detection and resistance profiling. Microorganisms. 13:14732025.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Miller S and Chiu C: The role of
metagenomics and next-generation sequencing in infectious disease
diagnosis. Clin Chem. 68:115–124. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Setterfield MA: Biomarker identification
and multiplex assay development for the detection of antimicrobial
resistance. Newcastle University; 2022
|
|
117
|
Heffernan AJ: Dose optimisation of
intravenous and nebulised antibiotics for the treatment of
Pseudomonas aeruginosa pneumonia. Griffith University; 2023
|
|
118
|
Budia-Silva M, Kostyanev T, Ayala-Montaño
S, Bravo-Ferrer Acosta J, Garcia-Castillo M, Cantón R, Goossens H,
Rodriguez-Baño J, Grundmann H and Reuter S: International and
regional spread of carbapenem-resistant Klebsiella
pneumoniae in Europe. Nat Commun. 15:50922024. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Zhang L, Chen J, Qu Y, Cao X, Cui J, Li J
and Yu A: Development and validation of a predictive model for
invasive syndrome in patients with Klebsiella pneumoniae
liver abscess. Front Med (Lausanne). 12:16634072025. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Pope JL, Yang Y, Newsome RC, Sun W, Sun X,
Ukhanova M, Neu J, Issa JP, Mai V and Jobin C: Microbial
colonization coordinates the pathogenesis of a Klebsiella
pneumoniae infant isolate. Sci Rep. 9:33802019. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Lin YT, Siu LK, Lin JC, Chen TL, Tseng CP,
Yeh KM, Chang FY and Fung CP: Seroepidemiology of Klebsiella
pneumoniae colonizing the intestinal tract of healthy Chinese
and overseas Chinese adults in Asian countries. BMC Microbiol.
12:132012. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
AL-Busaidi BN, AL-Muzahmi M, AL-Shabibi Z,
Rizvi M, AL-Rashdi A, AL-Jardani A, Farzand R and AL-Jabri Z:
klebsiella pneumoniae clinical strains of hypervirulent
capsular serotypes K1 and K2 demonstrating resistance against human
serum bactericidal activity and virulence in galleria mellonella
model. 2024. View Article : Google Scholar
|
|
123
|
Verani JR, Blau DM, Gurley ES, Akelo V,
Assefa N, Baillie V, Bassat Q, Berhane M, Bunn J, Cossa ACA, et al:
Child deaths caused by Klebsiella pneumoniae in sub-Saharan
Africa and south Asia: A secondary analysis of child health and
mortality prevention surveillance (CHAMPS) data. Lancet Microbe.
5:e131–e141. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Monteiro AdSS, Cordeiro SM and Reis JN:
Virulence factors in Klebsiella pneumoniae: A literature
review. Indian J Microbiol. 64:389–401. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Liao Y, Gong J, Yuan X, Wang X, Huang Y
and Chen X: Virulence factors and carbapenem-resistance mechanisms
in hypervirulent Klebsiella pneumoniae. Infect Drug Resist.
17:1551–1559. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Lam MMC, Wick RR, Wyres KL, Gorrie CL,
Judd LM, Jenney AWJ, Brisse S and Holt KE: Genetic diversity,
mobilisation and spread of the yersiniabactin-encoding mobile
element ICEKp in Klebsiella pneumoniae populations. Microb
Genom. 4:e0001962018.PubMed/NCBI
|
|
127
|
Bossuet-Greif N, Vignard J, Taieb F, Mirey
G, Dubois D, Petit C, Oswald E and Nougayrède JP: The colibactin
genotoxin generates DNA interstrand cross-links in infected cells.
mBio. 9:e02393–17. 2018. View Article : Google Scholar : PubMed/NCBI
|
